OGN vs. GSK
Compare and contrast key facts about Organon & Co. (OGN) and GlaxoSmithKline plc (GSK).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: OGN or GSK.
Correlation
The correlation between OGN and GSK is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
OGN vs. GSK - Performance Comparison
Key characteristics
OGN:
0.01
GSK:
-0.37
OGN:
0.30
GSK:
-0.39
OGN:
1.04
GSK:
0.95
OGN:
0.01
GSK:
-0.31
OGN:
0.03
GSK:
-0.61
OGN:
19.06%
GSK:
14.75%
OGN:
34.35%
GSK:
24.06%
OGN:
-69.56%
GSK:
-54.70%
OGN:
-54.29%
GSK:
-18.34%
Fundamentals
OGN:
$3.99B
GSK:
$74.71B
OGN:
$3.33
GSK:
$1.57
OGN:
4.65
GSK:
23.32
OGN:
$4.81B
GSK:
$23.26B
OGN:
$2.82B
GSK:
$16.84B
OGN:
$1.31B
GSK:
$6.82B
Returns By Period
In the year-to-date period, OGN achieves a 3.75% return, which is significantly lower than GSK's 8.25% return.
OGN
3.75%
-1.65%
-24.25%
-12.10%
N/A
N/A
GSK
8.25%
9.51%
-10.99%
-9.23%
5.98%
5.45%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
OGN vs. GSK — Risk-Adjusted Performance Rank
OGN
GSK
OGN vs. GSK - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Organon & Co. (OGN) and GlaxoSmithKline plc (GSK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
OGN vs. GSK - Dividend Comparison
OGN's dividend yield for the trailing twelve months is around 7.24%, more than GSK's 4.25% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
OGN Organon & Co. | 7.24% | 7.51% | 7.77% | 4.01% | 1.84% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
GSK GlaxoSmithKline plc | 4.25% | 4.60% | 3.75% | 4.78% | 6.14% | 6.86% | 5.34% | 6.93% | 7.13% | 8.82% | 7.43% | 7.60% |
Drawdowns
OGN vs. GSK - Drawdown Comparison
The maximum OGN drawdown since its inception was -69.56%, which is greater than GSK's maximum drawdown of -54.70%. Use the drawdown chart below to compare losses from any high point for OGN and GSK. For additional features, visit the drawdowns tool.
Volatility
OGN vs. GSK - Volatility Comparison
Organon & Co. (OGN) has a higher volatility of 15.86% compared to GlaxoSmithKline plc (GSK) at 10.25%. This indicates that OGN's price experiences larger fluctuations and is considered to be riskier than GSK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
OGN vs. GSK - Financials Comparison
This section allows you to compare key financial metrics between Organon & Co. and GlaxoSmithKline plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities